| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.6M | -21.3% |
| R&D Expense | $4.1M | +29.8% |
| SG&A Expense | $1.3M | -19.3% |
| Operating Income | -$138.4M | -22.3% |
| Interest Expense | $18.6M | +134.3% |
| Pre-tax Income | -$174.4M | +84.7% |
| Income Tax | $109K | — |
| Net Income | -$174.5M | +84.7% |
| EPS (Basic) | -$0.97 | +94.6% |
| EPS (Diluted) | -$0.97 | +94.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -25.2% |
| Accounts Receivable | $919K | -68.0% |
| Current Assets | $15.2M | -36.8% |
| Total Assets | $35.5M | -29.8% |
| Current Liabilities | $361.2M | +22.1% |
| Total Liabilities | $363.6M | +22.6% |
| Stockholders' Equity | -$328.1M | -33.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.9M | +10.7% |
| Investing Cash Flow | $1.5M | -59.3% |
| Financing Cash Flow | $19.6M | -18.5% |